Drug Trial Radar · NCT03558971
Patient Self-administration of Cortisol for Cortisol-responding Disorders in Men and Women Over the Age of 17
Last checked: Nov 19, 2026Latest source record: Jun 15, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,430
Actual
Start
Jan 1, 2000
Primary completion
Dec 31, 2016
Study completion Dec 31, 2016
Sponsor
- Lead sponsor
- Helen FoundationAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 15, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Participants diagnosed as having fibromyalgia, osteoarthritis, and rheumatoid arthritis are to be brought to a minimum symptom state using a 3-week period during which they are to ingest modest doses of cortisol tablets with weekly lowered tapered doses. Thereafter, the participants are to be taught to self-administer cortisol tablets on the as-needed basis to maintain the minimum symptom state. For this, they are to ingest a smaller-dosage, 5-day tapered regimen of cortisol tablets to quench each reoccurring exacerbation of the disease at its earliest stage. Participants are limited to using less than the safe use limit of cortisol per month and are required to include a minimum of 10 days per month during which no cortisol was ingested.
Conditions
- Rheumatic Diseases
Interventions
CortisolDrug
Participants determine when to administer 5-day regimens of cortisol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Participant evaluation of disease symptom intensityTime frame: Participants determine Total Scores 7 days prior to cortisol initiation to obtain the average baseline Total Score. Participant Total Score change is plotted daily vs. time for study. Outcome: Total Score at 24 weeks vs. baseline.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Helen Foundation Clinic
Apache Junction, Arizona
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.